| Literature DB >> 28927046 |
Haibo Wang1,2,3, Hao Gu1,2,3, Jun Feng1,2,3, Yayun Qian1,2,3, Lin Yang1,2,3, Feng Jin1,2,3, Xuanyi Wang1,2,3, Jue Chen1,2,3, Youyang Shi1,2,3, Songhua Lu1,2,3, Min Zhao1,2,3, Yanqing Liu1,2,3.
Abstract
Celastrus orbiculatus is a traditional medicinal plant used in the anti-inflammatory and analgesic treatment of various diseases. A previous study demonstrated that ethyl acetate extract of C. orbiculatus (COE) exhibited significant antitumor effects. However, studies concerning the effects and mechanism of COE in terms of suppressing the epithelial-mesenchymal transition (EMT) in human gastric adenocarcinoma cells have not been performed at present. The present study hypothesized that COE may inhibit EMT in gastric adenocarcinoma cells by regulating cell cytoskeleton rearrangement. The effect of COE on the viability of AGS cells was detected by MTT assay. An EMT model was induced by transforming growth factor-β1. Cell cytoskeleton staining, laser scanning confocal microscopy and electronic microscopy were used to detect the changes in cell morphology and microstructure of gastric adenocarcinoma cells prior and subsequent to COE treatment. Invasion and migration assays were used to observe the effect of COE on the metastatic ability of AGS cells in vitro. The effect of COE on the expression of Cofilin 1 and EMT biomarkers, including Epithelial-cadherin, Neural-cadherin, Vimentin and matrix metalloproteinases, was examined by western blotting in AGS cells. The correlation between Cofilin 1 and EMT was investigated with immunofluorescence and cytoskeleton staining methods. The results demonstrated that COE may significantly inhibit the process of EMT in AGS cells, and that this was concentration-dependent. In addition, COE significantly downregulated the level of Cofilin 1 in a concentration-dependent manner. In conclusion, these results suggested that Cofilin 1 was directly involved in the process of EMT in AGS cells, and that it served an important function. COE may significantly inhibit EMT in AGS cells, potentially by inhibiting the activation of the Cofilin 1 signaling pathway. The present study may provide a basis for the development of novel anticancer drugs and the development of novel therapeutic strategies, targeting Cofilin 1 protein.Entities:
Keywords: Celastrus orbiculatus; Cofilin 1; cytoskeleton; epithelial-mesenchymal transition; gastric cancer
Year: 2017 PMID: 28927046 PMCID: PMC5588110 DOI: 10.3892/ol.2017.6470
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967
Figure 1.(A) Morphological changes prior and subsequent to TGF-β1 treatment (magnification, x100). In the red box, cells were enlarged to show the formation of pseudopodia, indicated by the red arrows. (B) Changes to levels of epithelial-mesenchymal transition biomarkers prior and subsequent to TGF-β1 treatment. (C) Arrow 1 indicates cell filopodia and arrow 2 indicates cell lamellipodia. Arrow 3 indicates gradual alterations in cell morphology from the irregular polygon form of epithelial cells into the spindle or fusiform form of interstitial cells (magnification, x200). TGF-β1, transforming growth factor β1; E-cadherin, epithelial cadherin; N-cadherin, neural cadherin.
Figure 2.The inhibition of AGS cell viability induced by COE was concentration- and time-dependent. *P<0.05 and #P<0.01 vs. control. COE, Celastrus orbiculatus extract.
Figure 3.COE inhibits AGS cell invasion and metastasis (magnification, x100). COE, Celastrus orbiculatus extract; TGF-β1, transforming growth factor β1.
Inhibition of AGS cell invasion and metastasis by COE.
| Transforming growth factor-β1 (10 µg/l) | COE (mg/l) | No. of invading cells | No. of migrating cells |
|---|---|---|---|
| − | 0 | 110.4±7.64 | 221.8±29.56 |
| + | 0 | 137.8±6.38[ | 384.2±22.75[ |
| + | 10 | 105.4±9.24[ | 288.4±20.65[ |
| + | 20 | 77.8±7.92[ | 191.0±20.11[ |
| + | 40 | 38.4±13.35[ | 85.2±18.77[ |
P<0.05 vs. control;
P<0.05 vs. model. Data are presented as the mean ± standard deviation. COE, Celastrus orbiculatus extract.
Figure 4.(A) Cellular immune fluorescence: Cofilin 1 expression in AGS cells undergoing EMT, induced by TGF-β1. (B) Cytoskeleton staining: EMT was induced by TGF-β1 in AGS cells, and then cells were stained with tetramethylrhodamine-conjugated Phalloidin. (C) Nuclear DAPI staining in AGS cells. (D) Merged images: By combining immunofluorescence and cytoskeleton staining methods, it was possible to observe that an increased level of Cofilin 1 expression accompanied the stretching out of lamellipodia and filopodia in EMT-induced AGS cells. The arrows indicate typical EMT cells and demonstrate that expression of Cofilin 1 in these cells was marked, as the cell cytoplasm was dark green. Cells in the red box exhibited Cofilin 1 expression in normal control cells (magnification, x200). EMT, epithelial-mesenchymal transition; TGF-β1, transforming growth factor β1.
Figure 5.Changes in EMT biomarker expression levels following COE treatment for 24 h, was (A) assessed by western blotting and (B) quantified. Changes in the expression levels of MMPs following treatment with COE for 24 h was (C) assessed by western blotting and (D) quantified. *P<0.05 and **P<0.01 vs. control. EMT, epithelial-mesenchymal transition; COE, Celastrus orbiculatus extract; MMP, matrix metalloproteinase; E-cadherin, epithelial cadherin; N-cadherin, neural cadherin; TGF-β1, transforming growth factor β1.
Figure 6.Changes in cell morphology, cytoskeleton and microfilament structure and distribution (magnification, x400). As demonstrated in the figure, COE may significantly inhibit the rearrangement of the cytoskeleton, which may reduce the morphological changes of the cells and inhibit the epithelial-mesenchymal transition process. COE, Celastrus orbiculatus extract.